Neuroinflammation has been implicated in neurodegenerative diseases and acute brain injuries such as stroke. Monocyte chemotactic protein-1-induced protein-1 (Mcpip1) is a multifunction protein known to have pro-apoptotic or anti-apoptotic actions depending on the nature of experimental settings. However, its role in brain damage after asphyxia in the developing brain has not been studied. We, therefore, explored the role of Mcpip1 in brain injury after hypoxic-ischemia in neonatal mice. At postnatal day 7, Mcpip1-deficient and wild type mice underwent a carotid artery ligation and exposure to hypoxia (8% oxygen). After hypoxic-ischemic insult, we determined the time-course of apoptotic cell death and the expression levels of genes encoding proinflammatory factors. The impact of Mcpip1 on long-term brain damage was assessed 1 week post-hypoxic-ischemia by cresyl violet staining. We found caspase-3 activity was significantly increased in the ipsilateral brain tissues within 12–24 h after hypoxic-ischemia. There was a marked increase in the levels of mRNA transcripts encoding Mcpip1, TNFα, and CCL2 in the ipsilateral brain tissues 6–48 h after hypoxic-ischemia. We found hypoxic-ischemia-induced caspase-3 activity and the levels of the proinflammatory genes were attenuated in Mcpip1-knockout mice compared to wild type mice. Histological assessment revealed that hypoxic-ischemia-induced brain tissue loss was significantly attenuated in the hippocampus of Mcpip1-knockout mice than that of wild type mice (9.0 ± 5.6% vs. 33.9 ± 11.0%, P < 0.05). Our data suggest that Mcpip1 contributes to acute and delayed brain damage, in part, via regulation of neuroinflammation after hypoxic-ischemic insult in the developing mouse brain.
Neuroinflammation has been implicated with neurodegenerative diseases and acute brain injuries such as stroke. Monocyte chemotactic protein‐1‐induced protein‐1 (MCPIP1) is a multifunction inflammatory modulator known to have pro‐inflammatory or anti‐inflammatory effects depending on the nature of brain injury. However, its role in brain injury after asphyxia in the developing brain has not been studied. Therefore, we explored the role of MCPIP1 in acute neurodegeneration after hypoxic‐ischemia (HI) in the neonatal mouse model. Neonatal C57BL/6 wild type mice at postnatal day 7 (P7) underwent a carotid artery ligation and exposure to hypoxia (8% oxygen) for 42 minutes. After the HI insult, we determined the time‐course and the spatial distribution of MCPIP1 expression in the brain. To determine the impact of MCPIP1 in acute brain damage, we assessed brain tissue loss 1 week post‐HI brain injury in MCPIP1‐deficient versus wild type mice. Western blot analysis was used to determine MCPIP1 protein expression in the brain. Caspase‐3 activity assays were used to determine apoptotic cell death, and immunoflorescent double‐labeling was utilized to determine the scope of neuroinflammation in different types of cells including astrocytes, microglia, and neuronal cells. Our data revealed that MCPIP1 protein is expressed in the neonatal brain and its expression appears to increase 24 hours after HI insult. Immunostaining showed that MCPIP1 expressing cells are present in both neuronal and non‐neuronal cells of the brain, and that there are increased numbers of MCPIP1‐positive cells in the ipsi‐lateral hemisphere compared to the contra‐lateral hemisphere. Furthermore, there was significant change in brain tissue loss after HI in MCPIP‐1‐deficient mice compared with wild‐type mice. Our data suggest that HI brain injury appears to induce expression of MCPIP1, supporting a possible role of MCPIP1 in neuroinflammation after HI.Support or Funding InformationThis study is funded by KCOM‐ Biomedical Graduate Program, Warner/Ferumaturo Grant, and ATSU Start‐up Fund (BHH).This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.